Literature DB >> 26852054

Rheumatic heart disease in Indigenous children in northern Australia: differences in prevalence and the challenges of screening.

Kathryn V Roberts1, Graeme P Maguire2, Alex Brown3, David N Atkinson4, Bo Remenyi5, Gavin Wheaton6, Marcus Ilton5, Jonathan Carapetis7.   

Abstract

OBJECTIVES: To compare regional differences in the prevalence of rheumatic heart disease (RHD) detected by echocardiographic screening in high-risk Indigenous Australian children, and to describe the logistical and other practical challenges of RHD screening.
DESIGN: Cross-sectional screening survey performed between September 2008 and November 2010.
SETTING: Thirty-two remote communities in four regions of northern and central Australia. PARTICIPANTS: 3946 Aboriginal or Torres Strait Islander children aged 5-15 years. INTERVENTION: Portable echocardiography was performed by cardiac sonographers. Echocardiograms were recorded and reported offsite by a pool of cardiologists. MAIN OUTCOME MEASURES: RHD was diagnosed according to 2012 World Heart Federation criteria.
RESULTS: The prevalence of definite RHD differed between regions, from 4.7/1000 in Far North Queensland to 15.0/1000 in the Top End of the Northern Territory. The prevalence of definite RHD was greater in the Top End than in other regions (odds ratio, 2.3; 95% CI, 1.2-4.6, P = 0.01). Fifty-three per cent of detected cases of definite RHD were new cases; the prevalence of new cases of definite RHD was 4.6/1000 for the entire sample and 7.0/1000 in the Top End. Evaluation of socioeconomic data suggests that the Top End group was the most disadvantaged in our study population.
CONCLUSIONS: The prevalence of definite RHD in remote Indigenous Australian children is significant, with a substantial level of undetected disease. Important differences were noted between regions, with the Top End having the highest prevalence of definite RHD, perhaps explained by socioeconomic factors. Regional differences must be considered when evaluating the potential benefit of widespread echocardiographic screening in Australia.

Entities:  

Mesh:

Year:  2015        PMID: 26852054     DOI: 10.5694/mja15.00139

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  15 in total

1.  Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever.

Authors:  Madhu Page-Sharp; Jonathan Coward; Brioni R Moore; Sam Salman; Lewis Marshall; Timothy M E Davis; Kevin T Batty; Laurens Manning
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

2.  Inter-rater and intra-rater reliability and agreement of echocardiographic diagnosis of rheumatic heart disease using the World Heart Federation evidence-based criteria.

Authors:  Bo Remenyi; Jonathan Carapetis; John W Stirling; Beatrice Ferreira; Krishnan Kumar; John Lawrenson; Eloi Marijon; Mariana Mirabel; A O Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; Satu Viali; I B Vijayalakshmi; Gavin R Wheaton; Liesl Zuhlke; Karishma Sidhu; Eliazar Dimalapang; Thomas L Gentles; Nigel J Wilson
Journal:  Heart Asia       Date:  2019-06-24

3.  Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost-Utility Analysis.

Authors:  Kathryn Roberts; Jeffrey Cannon; David Atkinson; Alex Brown; Graeme Maguire; Bo Remenyi; Gavin Wheaton; Elizabeth Geelhoed; Jonathan R Carapetis
Journal:  J Am Heart Assoc       Date:  2017-03-02       Impact factor: 5.501

4.  A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.

Authors:  Robert M Hand; Sam Salman; Nelly Newall; Julie Vine; Madhu Page-Sharp; Asha C Bowen; Katherine Gray; Amy Baker; Joseph Kado; John Joseph; Julie Marsh; James Ramsay; Dianne Sika-Paotonu; Kevin T Batty; Laurens Manning; Jonathan Carapetis
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

5.  How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease.

Authors:  Jessica Langloh de Dassel; Nick de Klerk; Jonathan Rhys Carapetis; Anna P Ralph
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

6.  Prevalence and prognostic value of echocardiographic screening for rheumatic heart disease.

Authors:  Susy Kotit; Karim Said; Amr ElFaramawy; Hani Mahmoud; David I W Phillips; Magdi H Yacoub
Journal:  Open Heart       Date:  2017-12-17

7.  The RECARDINA Study protocol: diagnostic utility of ultra-abbreviated echocardiographic protocol for handheld machines used by non-experts to detect rheumatic heart disease.

Authors:  Joshua Reginald Francis; Helen Fairhurst; Gillian Whalley; Alex Kaethner; Anna Ralph; Jennifer Yan; James Cush; Vicki Wade; Andre Monteiro; Bo Remenyi
Journal:  BMJ Open       Date:  2020-05-27       Impact factor: 2.692

8.  Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.

Authors:  Anna P Ralph; Jessica L de Dassel; Adrienne Kirby; Clancy Read; Alison G Mitchell; Graeme P Maguire; Bart J Currie; Ross S Bailie; Vanessa Johnston; Jonathan R Carapetis
Journal:  J Am Heart Assoc       Date:  2018-07-17       Impact factor: 5.501

Review 9.  The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review.

Authors:  Pasqualina M Coffey; Anna P Ralph; Vicki L Krause
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

Review 10.  Global epidemiology of valvular heart disease.

Authors:  Sean Coffey; Ross Roberts-Thomson; Alex Brown; Jonathan Carapetis; Mao Chen; Maurice Enriquez-Sarano; Liesl Zühlke; Bernard D Prendergast
Journal:  Nat Rev Cardiol       Date:  2021-06-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.